AKT1 and cancer: In addition, the amounts of Akt phosphorylation (Kai et al. 2023), mTOR, and c‐Myc in cancer cells were reduced after theaflavin treatment (Dalei et al. 2022), which are typically overexpressed in normal cancer cells.